-
Article
Open AccessPoor quality vital anti-malarials in Africa - an urgent neglected public health priority
Plasmodium falciparum malaria remains a major public health problem. A vital component of malaria control rests on the availability of good quality artemisinin-derivative based combination therapy (ACT) at the co...
-
Article
Open AccessThe challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and ha...
-
Article
Open AccessThe cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets
Fever is the clinical hallmark of malaria disease. The Roll Back Malaria (RBM) movement promotes prompt, effective treatment of childhood fevers as a key component to achieving its optimistic mortality reducti...
-
Article
Open AccessWealth, mother's education and physical access as determinants of retail sector net use in rural Kenya
Insecticide-treated bed nets (ITN) provide real hope for the reduction of the malaria burden across Africa. Understanding factors that determine access to ITN is crucial to debates surrounding the optimal deli...
-
Article
Open AccessBrands, costs and registration status of antimalarial drugs in the Kenyan retail sector
Although an important source of treatment for fevers, little is known about the structure of the retail sector in Africa with regard to antimalarial drugs. This study aimed to assess the range, costs, sources ...
